Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for ASND on January 27, 2026 09:23PM ET. ASND was trading at $238.8 at issue of the analyst recommendation.The overall analyst consensus :...

January 27, 2026   ASND -0.95%

Barclays analyst issues OVERWEIGHT recommendation for IVA on January 27, 2026 09:24PM ET. IVA was trading at $6.87 at issue of the analyst recommendation.The overall analyst consensus :...

January 27, 2026   IVA -0.32%

Morgan Stanley analyst issues OVERWEIGHT recommendation for RYAAY on January 27, 2026 04:26PM ET. The previous analyst recommendation was Overweight.RYAAY was trading at $68 at issue of the...

January 27, 2026   RYAAY 0.41%

Morgan Stanley analyst issues UNDERWEIGHT recommendation for FMS on January 27, 2026 04:26PM ET. The previous analyst recommendation was Underweight.FMS was trading at $22.255 at issue of the...

January 27, 2026   FMS -0.10%

H.C. Wainwright analyst issues BUY recommendation for MOLN on January 27, 2026 11:06AM ET. MOLN was trading at $4 at issue of the analyst recommendation.The overall analyst consensus...

January 27, 2026   MOLN -0.97%

Barclays analyst issues OVERWEIGHT recommendation for CX on January 27, 2026 10:43AM ET. The previous analyst recommendation was Overweight.CX was trading at $12.76 at issue of the analyst...

January 27, 2026   CX 2.44%

Citigroup analyst issues BUY recommendation for AZN on January 27, 2026 09:29AM ET. AZN was trading at $94.23 at issue of the analyst recommendation.The overall analyst consensus :...

January 27, 2026   AZN 0.39%

Citigroup analyst issues BUY recommendation for NVS on January 27, 2026 09:30AM ET. NVS was trading at $149.12 at issue of the analyst recommendation.The overall analyst consensus :...

January 27, 2026   NVS 1.19%

Citigroup analyst issues NEUTRAL recommendation for NVO on January 27, 2026 09:31AM ET. NVO was trading at $63.98 at issue of the analyst recommendation.The overall analyst consensus :...

January 27, 2026   NVO 1.31%

Citigroup analyst issues NEUTRAL recommendation for GSK on January 27, 2026 09:33AM ET. The previous analyst recommendation was Buy.GSK was trading at $50.32 at issue of the analyst...

January 27, 2026   GSK 0.60%